• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

喀麦隆结核病低报告地区的测绘及诊断差距估计:来自开放街道地图和世界人口数据的证据

Mapping of regions with low tuberculosis notification and estimation of diagnostic gaps in Cameroon, evidence from OpenStreetMap and WorldPop data.

作者信息

Jouego Christelle Geneviève, Collins Titahong Nosoh, Tegomoh Bryan, Geenen Caspar, Netongo Palmer Masumbe, André Emmanuel, Faccin Mauro

机构信息

Molecular Diagnostics Research Group (MDRG), University of Yaoundé 1, Yaoundé, Cameroon.

Laboratory of Clinical Microbiology, Department of Microbiology, Immunology and Transplantation, KU Leuven, Herestraat 49, 3000, Leuven, Belgium.

出版信息

Sci Rep. 2025 Feb 10;15(1):4992. doi: 10.1038/s41598-025-87682-5.

DOI:10.1038/s41598-025-87682-5
PMID:39929893
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11811050/
Abstract

Since 2012, Cameroon has introduced rapid molecular diagnostic tests for tuberculosis (TB). Despite this progress, WHO estimates indicate a TB diagnostic gap of 43% at the national level in 2019. This raises questions about the strategic allocation of available rapid molecular diagnostic tools to areas with lower TB notification. In a cross-sectional study, we combined Cameroon notification data on TB (2019), rifampicin-resistant (RR)-TB (2015-2019), as well as local TB risk factors, availability, intensity of use and accessibility of the Xpert MTB-RIF test with openly available geospatial datasets from OpenStreetMap and WorldPop. A mathematical model estimated TB and RR-TB incidence rates at the regional level. We compared these estimates with the number of reported TB cases to identify diagnostic gaps. Centre, East and Far North regions had the highest estimated TB incidence rates (400, 300 and 200 cases per 100,000 inhabitants, respectively), while South and Adamawa had the highest estimated RR-TB incidence rates (14.9 and 8.9 cases per 100,000 inhabitants, respectively). We report a national diagnostic gap of 53% and 50% for TB and RR-TB, respectively. These findings highlight the need to improve the allocation of diagnostic tools that follows the local disease burden in resource-limited settings to improve health equity.

摘要

自2012年以来,喀麦隆已引入结核病快速分子诊断检测。尽管取得了这一进展,但世界卫生组织的估计表明,2019年全国结核病诊断缺口为43%。这引发了关于将现有的快速分子诊断工具战略分配到结核病通报率较低地区的问题。在一项横断面研究中,我们将喀麦隆的结核病(2019年)、耐利福平结核病(RR-TB,2015 - 2019年)通报数据,以及当地结核病风险因素、Xpert MTB-RIF检测的可用性、使用强度和可及性,与来自OpenStreetMap和WorldPop的公开地理空间数据集相结合。一个数学模型估计了区域层面的结核病和RR-TB发病率。我们将这些估计值与报告的结核病病例数进行比较,以确定诊断缺口。中部、东部和远北地区的估计结核病发病率最高(分别为每10万居民400例、300例和200例),而南部和阿达马瓦地区的估计RR-TB发病率最高(分别为每10万居民14.9例和8.9例)。我们报告全国结核病和RR-TB的诊断缺口分别为53%和50%。这些发现凸显了在资源有限的环境中,需要根据当地疾病负担改进诊断工具的分配,以促进健康公平。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a210/11811050/02bcd28c7819/41598_2025_87682_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a210/11811050/f15b65ad5624/41598_2025_87682_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a210/11811050/e237c4635b03/41598_2025_87682_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a210/11811050/02bcd28c7819/41598_2025_87682_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a210/11811050/f15b65ad5624/41598_2025_87682_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a210/11811050/e237c4635b03/41598_2025_87682_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a210/11811050/02bcd28c7819/41598_2025_87682_Fig4_HTML.jpg

相似文献

1
Mapping of regions with low tuberculosis notification and estimation of diagnostic gaps in Cameroon, evidence from OpenStreetMap and WorldPop data.喀麦隆结核病低报告地区的测绘及诊断差距估计:来自开放街道地图和世界人口数据的证据
Sci Rep. 2025 Feb 10;15(1):4992. doi: 10.1038/s41598-025-87682-5.
2
Rifampicin resistance in new bacteriologically confirmed pulmonary tuberculosis patients in Cameroon: a cross-sectional survey.喀麦隆新确诊的细菌学确诊肺结核患者中的利福平耐药性:一项横断面调查。
BMC Res Notes. 2018 Aug 13;11(1):580. doi: 10.1186/s13104-018-3675-0.
3
Predictors of Drug-Resistant Tuberculosis among High-Risk Population Diagnosed under National Program Conditions in the Littoral Region, Cameroon.喀麦隆滨海地区国家项目条件下诊断的高危人群中耐药结核病的预测因素。
Biomed Res Int. 2021 Nov 19;2021:8817442. doi: 10.1155/2021/8817442. eCollection 2021.
4
Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.用于检测成人肺结核及利福平耐药性的Xpert® MTB/RIF检测法
Cochrane Database Syst Rev. 2014 Jan 21;2014(1):CD009593. doi: 10.1002/14651858.CD009593.pub3.
5
A cost-benefit algorithm for rapid diagnosis of tuberculosis and rifampicin resistance detection during mass screening campaigns.一种用于大规模筛查活动中快速诊断结核病和利福平耐药性检测的成本效益算法。
BMC Infect Dis. 2022 Mar 4;22(1):219. doi: 10.1186/s12879-022-07157-0.
6
Use of Xpert MTB/RIF in Decentralized Public Health Settings and Its Effect on Pulmonary TB and DR-TB Case Finding in India.在印度分散式公共卫生环境中使用Xpert MTB/RIF及其对肺结核和耐多药肺结核病例发现的影响。
PLoS One. 2015 May 21;10(5):e0126065. doi: 10.1371/journal.pone.0126065. eCollection 2015.
7
Impact of replacing smear microscopy with Xpert MTB/RIF for diagnosing tuberculosis in Brazil: a stepped-wedge cluster-randomized trial.在巴西用Xpert MTB/RIF取代涂片显微镜检查诊断结核病的影响:一项阶梯式楔形整群随机试验
PLoS Med. 2014 Dec 9;11(12):e1001766. doi: 10.1371/journal.pmed.1001766. eCollection 2014 Dec.
8
Impact of Xpert MTB/RIF in the Diagnosis of Childhood Tuberculosis in Rural Ethiopia.Xpert MTB/RIF 在埃塞俄比亚农村地区儿童结核病诊断中的影响。
J Trop Pediatr. 2022 Jun 6;68(4). doi: 10.1093/tropej/fmac055.
9
Xpert MTB/RIF and Xpert Ultra assays for screening for pulmonary tuberculosis and rifampicin resistance in adults, irrespective of signs or symptoms.Xpert MTB/RIF 和 Xpert Ultra 检测用于筛查成人肺结核和利福平耐药,无论有无症状。
Cochrane Database Syst Rev. 2021 Mar 23;3(3):CD013694. doi: 10.1002/14651858.CD013694.pub2.
10
Xpert MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance.用于肺外结核病和利福平耐药性的Xpert MTB/RIF检测
Cochrane Database Syst Rev. 2018 Aug 27;8(8):CD012768. doi: 10.1002/14651858.CD012768.pub2.

本文引用的文献

1
Integrating Molecular Diagnostics and GIS Mapping: A Multidisciplinary Approach to Understanding Tuberculosis Disease Dynamics in South Africa Using Xpert MTB/RIF.整合分子诊断与地理信息系统绘图:一种运用Xpert MTB/RIF了解南非结核病疾病动态的多学科方法。
Diagnostics (Basel). 2023 Oct 10;13(20):3163. doi: 10.3390/diagnostics13203163.
2
Tuberculosis-loop-mediated isothermal amplification implementation in Cameroon: Challenges, lessons learned and recommendations.喀麦隆结核环介导等温扩增技术的应用:挑战、经验教训与建议
Afr J Lab Med. 2022 Aug 26;11(1):1792. doi: 10.4102/ajlm.v11i1.1792. eCollection 2022.
3
Data-driven identification of communities with high levels of tuberculosis infection in the Democratic Republic of Congo.
基于数据的刚果民主共和国结核感染高发社区识别。
Sci Rep. 2022 Mar 10;12(1):3912. doi: 10.1038/s41598-022-07633-2.
4
Patient-Pathway Analysis of Tuberculosis Services in Cameroon.喀麦隆结核病服务的患者路径分析
Trop Med Infect Dis. 2021 Sep 22;6(4):171. doi: 10.3390/tropicalmed6040171.
5
A household-level score to predict the risk of tuberculosis among contacts of patients with tuberculosis: a derivation and external validation prospective cohort study.基于家庭的评分系统预测肺结核患者接触者患肺结核的风险:一项推导和外部验证的前瞻性队列研究。
Lancet Infect Dis. 2020 Jan;20(1):110-122. doi: 10.1016/S1473-3099(19)30423-2. Epub 2019 Oct 31.
6
Spatial analysis of HIV-TB co-clustering in Uganda.乌干达 HIV-TB 共感染的空间分析。
BMC Infect Dis. 2019 Jul 12;19(1):612. doi: 10.1186/s12879-019-4246-2.
7
Disparities in access to diagnosis and care in Blantyre, Malawi, identified through enhanced tuberculosis surveillance and spatial analysis.在马拉维布兰太尔,通过强化结核病监测和空间分析发现了在诊断和治疗方面存在的差距。
BMC Med. 2019 Jan 29;17(1):21. doi: 10.1186/s12916-019-1260-6.
8
Methods used in the spatial analysis of tuberculosis epidemiology: a systematic review.结核病流行病学空间分析方法:系统评价。
BMC Med. 2018 Oct 18;16(1):193. doi: 10.1186/s12916-018-1178-4.
9
Implementing rapid testing for tuberculosis in Mozambique.在莫桑比克实施结核病快速检测。
Bull World Health Organ. 2015 Feb 1;93(2):125-30. doi: 10.2471/BLT.14.138560. Epub 2014 Nov 26.